Literature DB >> 2429785

Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth.

B Fellström, B G Danielson, S Ljunghall, B Wikström.   

Abstract

The inhibition of calcium oxalate crystal growth by the glycosaminoglycans, chondroitin sulphates and heparin, by the low-molecular-weight heparin analogue pentosan polysulphate and by Tamm-Horsfall glycoprotein extracted from human urine, was measured by using a seeded crystal procedure and compared with the inhibition by pyrophosphate. It was found that the most pronounced inhibition was obtained with the polyanions with the highest charge density, i.e., heparin and pentosan polysulphate. Tamm-Horsfall glycoprotein caused an inhibition of a similar magnitude as urinary chondroitin sulphates. Urinary polyanions with a high affinity to Sepharose 4B were more efficient inhibitors than those with a low or no affinity to the gel. It is concluded that urinary polyanions are important inhibitors of calcium oxalate crystal growth and that the potency of inhibition increases with the charge density.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429785     DOI: 10.1016/0009-8981(86)90286-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

Review 1.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 2.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

Review 3.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.

Authors:  D Senthil; K Subha; N Saravanan; P Varalakshmi
Journal:  Mol Cell Biochem       Date:  1996-03-09       Impact factor: 3.396

Review 5.  Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques.

Authors:  Xue-Ru Wu
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

6.  Mineralogy and chemistry of urinary stones: patients from North Jordan.

Authors:  Iyad Ahmed Abboud
Journal:  Environ Geochem Health       Date:  2007-12-07       Impact factor: 4.609

7.  Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate.

Authors:  B Fellström; U Backman; B Danielson; B Wikström
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

8.  Heparan sulfate gene polymorphism in calcium oxalate nephrolithiasis.

Authors:  Metin Onaran; Akin Yilmaz; Ilker Sen; Mehmet Ali Ergun; Ahmet Camtosun; Bora Küpeli; Sevda Menevse; Ibrahim Bozkirli
Journal:  Urol Res       Date:  2008-12-09

Review 9.  Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.

Authors:  Kanu Priya Aggarwal; Shifa Narula; Monica Kakkar; Chanderdeep Tandon
Journal:  Biomed Res Int       Date:  2013-09-14       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.